Healthcare, Pharma & Life Sciences

Golisano's $40M Gift Renames Colorado Springs Children's Hospital

Image
Golisano's $40M Gift Renames Colorado Springs Children's Hospital

Colorado Springs – September 16, 2026 -- Children's Hospital Colorado, Colorado Springs will be renamed Children's Hospital Colorado, Golisano Children's Hospital, Colorado Springs, effective immediately, following a $40 million gift from entrepreneur and philanthropist Tom Golisano.

Gift marks largest philanthropic donation in Children's Colorado history

The $40 million contribution, dedicated exclusively to the Colorado Springs facility, accompanies the hospital's induction into the Golisano Children's Alliance, a national initiative launched in 2025 that coordinates strategic funding across member children's hospitals to expand pediatric services and strengthen collaboration.

AI Virtual Medical Assistant Market to Hit $12.3B by 2031

Image
AI Virtual Medical Assistant Market to Hit $12.3B by 2031

Sheridan, Wyo. – September 16, 2026 -- The global AI in virtual medical assistant market is set to expand from $2.6 billion in 2026 to $12.3 billion by 2031, a compound annual growth rate of 36.5%, according to a new study by Wissen Research.

EHR-integrated systems dominate the market with 42-48% share

EHR/EMR-integrated systems led the market by offering type in 2025, accounting for an estimated 42-48% of global revenue, as healthcare providers favor solutions embedded directly into existing clinical workflows over standalone applications.

RCM Market to Nearly Double to $132 Billion by 2031 as AI Reshapes Billing

Image
RCM Market to Nearly Double to $132 Billion by 2031 as AI Reshapes Billing

Delray Beach, Fla. – – September 16, 2026 -- The global Revenue Cycle Management market is projected to reach USD 132.06 billion by 2031, up from USD 73.61 billion in 2026, expanding at a compound annual growth rate of 12.4%, according to MarketsandMarkets.

North America controls 40% of the RCM market as denial rates push AI adoption

North America held a 40.0% share of the global RCM market in 2025, driven by a fragmented US payer landscape and rising claim denial rates that are pushing hospital networks toward AI-assisted coding and predictive denial analytics. Small and medium-sized enterprises are the fastest-growing enterprise segment, expanding at a 13.0% CAGR, while on-premises deployment still commands 56.4% of the market despite the shift toward cloud platforms.

Obesity Drug Market Hits $16B as Lilly, Novo Face New Rivals

Image
Obesity Drug Market Hits $16B as Lilly, Novo Face New Rivals

Las Vegas – – September 16, 2026 -- The obesity therapeutics market across the seven major markets was valued at approximately USD 16 billion in 2025 and is projected to grow at a 27% CAGR through 2036, according to DelveInsight, as a wave of next-generation candidates threatens to disrupt the Eli Lilly-Novo Nordisk duopoly.

Oral GLP-1 Therapies Accelerate Patient Uptake

Novo Nordisk's oral WEGOVY surpassed 5 million cumulative U.S. prescriptions within 30 weeks of launch, while Eli Lilly's oral FOUNDAYO (orforglipron) gained significant traction among patients initiating obesity treatment by mid-2026. Aparna Thakur, Project Manager of Forecasting & Analytics at DelveInsight, said FOUNDAYO's once-daily oral formulation positions it for rapid uptake as a more convenient alternative to injectable therapies.

Response Media Launches RE:HEALTH, AI Tool to Cut $300B Adherence Gap

Image
Response Media Launches RE:HEALTH, AI Tool to Cut $300B Adherence Gap

Atlanta – September 16, 2026 -- Medication nonadherence costs the U.S. healthcare system as much as $300 billion annually, a gap Response Media is targeting with the launch of a new health and life sciences practice called RE:HEALTH.

Response Media debuts AdherenceIQ to predict patient drop-off before it happens

The agency introduced AdherenceIQ, a proprietary AI-powered behavioral intelligence platform designed to predict which patients will discontinue therapy and why. The tool combines behavioral science, privacy-compliant AI and advanced analytics to identify emotional and functional barriers to treatment, including concerns about side effects, necessity, distrust and stigma.

NYU Langone Names Sean Berry Vice Chair of Radiation Oncology Physics

Image
NYU Langone Names Sean Berry Vice Chair of Radiation Oncology Physics

New York – September 16, 2026 -- NYU Langone Health's Perlmutter Cancer Center has named Sean L. Berry, PhD, vice chair of physics and dosimetry in its Department of Radiation Oncology, recruiting a 20-year veteran of Memorial Sloan Kettering Cancer Center to lead treatment-planning quality and safety programs.

Berry moves from a regional physicist role overseeing multi-site radiation oncology operations

Before joining NYU Langone, Berry served as regional lead physicist and associate attending physicist at Memorial Sloan Kettering Cancer Center, managing clinical physics operations across outpatient sites in Westchester County, New York, and Bergen County, New Jersey. His duties included supervising faculty physicists, staff physicists and dosimetrists, regulatory readiness, accreditation activities, budget oversight, linear accelerator commissioning and standardizing radiation oncology practice across multiple locations.

Noom CEO Proposes 'Habit Window' Framework to Fix GLP-1 Dropout Rates

Toronto – September 16, 2026 -- A new viewpoint paper published in the Journal of Medical Internet Research argues that GLP-1 weight-loss drugs fail long-term without paired digital behavioral coaching, citing high patient dropout and rapid weight regain as persistent industry problems. The paper, authored by Noom CEO Geoff Cook, introduces a "habit window hypothesis" and calls for a formal research agenda to test whether digital health apps can extend the durability of pharmacological weight loss.

SQAIRZ Launches Medical Division to Tackle $80B Fall-Risk Crisis

Windham, N.H. – September 16, 2026 -- SQAIRZ, a biomechanically driven performance footwear company, has launched SQAIRZ Medical, a new division targeting fall risk among aging adults through a combined footwear and clinical assessment platform.

Fall injuries cost the U.S. healthcare system more than $80 billion annually

One in four U.S. adults over age 65 falls at least once a year, a figure that rises to one in two for adults over 80, according to SQAIRZ. The company positions SENTRX, its purpose-built Balance & Stability footwear, as the centerpiece of a broader clinical framework aimed at reducing that risk.

Healthcare Success, Inlets.ai Partner on AI Patient Discovery Tools

Tustin, Calif. – September 16, 2026 -- Healthcare Success has partnered with Inlets.ai to help hospitals and multi-location health systems monitor and improve how they appear when patients search using AI platforms like ChatGPT, Gemini, and Google AI.

Patient discovery shifts from search engines to AI chat platforms before hospital websites are ever visited

Patients increasingly research providers, treatments, and hospitals through AI platforms before reaching a healthcare organization's website, according to the companies. This shift creates a new challenge for health systems: understanding what AI tools are telling prospective patients about their physicians, locations, service lines, and brands.

Biological Safety Cabinet Market to Hit $0.36B by 2031, Kewaunee Leads M&A

Image
Biological Safety Cabinet Market to Hit $0.36B by 2031, Kewaunee Leads M&A

Delray Beach, Fla. – September 16, 2026 -- The global biological safety cabinet market is projected to grow from USD 0.26 billion in 2026 to USD 0.36 billion by 2031, a 6.6% CAGR, according to MarketsandMarkets.

Pharma investment and biosafety upgrades drive containment equipment demand

Expansion of drug discovery, biologics, cell and gene therapy, and vaccine development is pushing laboratories to replace aging cabinets with certified, higher-performance containment systems. Rising biosafety requirements for handling infectious agents and hazardous materials are accelerating both new installations and equipment upgrades across clinical, academic, and pharmaceutical labs.